Dynavax Technologies | Capitale Sociale E Riserve

Equity Capital And Reserves Cambiamento Data
Adma Biologics USD 135.21M 16.23M 2023-12
Amgen USD 6.23B 1.42B 2023-12
AstraZeneca USD 37.2B 195M 2023-09
Dynavax Technologies USD 622.07M 17.16M 2023-12
Gilead Sciences USD 22.75B 435M 2023-12
Neurocrine Biosciences USD 2B 149.1M 2023-09
Pfizer USD 96.93B 2.08B 2023-09
Regeneron Pharmaceuticals USD 25.97B 1.07B 2023-12
Roche Holding CHF 26.52B 1.48B 2023-06
Sarepta Therapeutics USD 764.36M 22.95M 2023-09
TG Therapeutics USD 160.5M 4.27M 2023-12
Vertex Pharmaceuticals USD 16.51B 1.04B 2023-09



Dynavax Technologies Capitale Sociale E Riserve - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Apr 2024.